Skip to main content
SpringerLink
Log in

In vivo models for testing of cytostatic agents in non-small cell lung cancer

  • Chapter
Lung Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 72))

  • 125 Accesses

Abstract

The limited progress in non-small cell lung cancer (NSCLC) in numerous clinical trials is rather disappointing. There is a need for more detailed information on the specific biological properties of the various forms of lung cancer before a more rational approach in the improvement of treatment can be made. In contrast to the situation in other forms of cancer, e.g., lymphoid and myeloid leukemia, mammary cancer, and colon cancer, there has been a noticeable scarcity of useful animal models for the study of the biological properties of lung tumors and their responsiveness to chemo-therapeutics and radiation. In general, a particular tumor model should be chosen based upon the specific question to be answered. One of the major areas of research is response to treatment. Human lung tumor xenografts have been used as tools to study responsiveness to treatment modalities, and rodent lung tumor models were developed that can be used for this purpose. In this chapter, the xenograft model and the rodent lung tumor models will be described with respect to their responsiveness to cytostatic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 429.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 549.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Shimosato Y, Karaeya T, Nagai K, Hirohashi S, Koide T, Hayashi H, Nomura T. 1976. Transplantation of human tumors in nude mice. J Natl Cancer Inst 56:1251–1260.

    PubMed  CAS  Google Scholar 

  2. Giovanella BC, Stehlin JS, Williams LJ, Lee SS, Shephard RC. 1978. Heterotransplantation of human cancers into nude mice. Cancer 42:2269–2281.

    Article  PubMed  CAS  Google Scholar 

  3. Fogh J, Orfeo T, Tiso J, Sharkey FE, Fogh JM, Daniels WP. 1980. Twenty-three new human tumor lines established in nude mice. Exp Cell Biol 48:229–239.

    PubMed  CAS  Google Scholar 

  4. Gazdar AF, Carney DN, Sims HL, Simmons A. 1981. Heterotransplantation of small cell carcinoma of the lung into nude mice: comparison of intracranial and subcutaneous routes. Int J Cancer 28:777–783.

    Article  PubMed  CAS  Google Scholar 

  5. Kallman RF. 1987. Commentary on part 8. In Rodent Tumor Models in Experimental Cancer Therapy, RF Kallman (ed.). Pergamon Press: New York, pp. 197–198.

    Google Scholar 

  6. Houghton JA, Houghton PJ. 1987. The suitability and use of human tumor xenografts. In Rodent Tumor Models in Experimental Cancer Therapy, RF Kallman (ed.). Pergamon Press: New York, pp. 199–204.

    Google Scholar 

  7. Steel GG. 1987. How well do xenografts maintain the therapeutic response characteristics of the source tumor in the donor patient? In Rodent Tumor Models in Experimental Cancer Therapy, RF Kallman (ed.). Pergamon Press: New York, pp. 205–208.

    Google Scholar 

  8. Rofstad EK. 1987. Radioresponsiveness of human tumor xenografts: Growth delay and vascular damage. In Rodent Tumor Models in Experimental Cancer Therapy, RF Kallman (ed.). Pergamon Press: New York, pp. 209–213.

    Google Scholar 

  9. Bepler G, Neumann K. 1990. Nude mouse xenografts as in vivo models for lung carcinomas. In Vivo 4:309–316.

    CAS  Google Scholar 

  10. Shorthouse AJ, Peckham MJ, Smyth JF, Steel GG. 1980. The therapeutic response of bronchial carcinoma xenografts: A direct patient-xenograft comparison. Br J Cancer 41(Suppl IV): 142–145.

    Google Scholar 

  11. Steel GG, Courtenay VD, Peckham MJ. 1983. The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer 47:1–13.

    Article  PubMed  CAS  Google Scholar 

  12. Ovejera AA. 1987. The use of human tumor xenografts in large-scale drug screening. In Rodent Tumor Models in Experimental Cancer Therapy, RF Kallman (ed.). Pergamon Press: New York, pp. 218–220.

    Google Scholar 

  13. Bellet RE, Danna V, Mastrangelo MJ, Berd D. 1979. Evaluation of a nude mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents. J Natl Cancer Inst 63:1185–1188.

    PubMed  CAS  Google Scholar 

  14. Kal HB, Van Bekkum DW. 1988. Comparison of chemosensitivity of transplantable non-small cell bronchial tumours of rats in syngeneic hosts and in nude rodents. Eur J Cancer Clin Oncol 24:999–1003.

    Article  PubMed  CAS  Google Scholar 

  15. Sugiura K, Stock CC. 1955. Studies in a tumor spectrum III. The effect of phosphoramides on the growth of a variety of mouse and rat tumours. Cancer Res 15:38.

    PubMed  CAS  Google Scholar 

  16. Carter SK, Schabel FM, Broder LE, Johnston TP. 1972. 1,3-Bis(2-chloro-ethyl)-1-nitrosourea (BCNU) and other nitrosoureas in cancer treatment. A review. In Advances in Cancer Research, Vol. 16. Academic Press: New York, London, p. 292.

    Google Scholar 

  17. Pratesi G, Pezzoni G, Parmiani G. 1985. NMU-1, a new transplantable mouse lung tumor: biological and chemosensitivity properties in vivo. Cancer Treat Rep 69:219–221.

    PubMed  CAS  Google Scholar 

  18. Layton MG, Franks LM. 1984. Heterogeneity in a spontaneous mouse lung carcinoma: selection and characteristics of stable metastatic variants. Br J Cancer 49:415–421.

    Article  PubMed  CAS  Google Scholar 

  19. Kal HB, Zürcher C, Van Bekkum DW. 1986. Induction of lung tumors by radioactive isotopes implanted in the rat lung. J Natl Cancer Inst 7:943–946.

    Google Scholar 

  20. Klein JC, Zürcher C, Van Bekkum DW. 1987. Differential behavior of human bronchial carcinoma cells in culture. Cancer Res 47:2351–2358.

    Google Scholar 

  21. Barendsen GW, Broerse JJ. 1969. Experimental radiotherapy of a rat rhabdomyosarcoma with 15MeV neutrons and 300kV X-rays. I. Effects of single exposures. Eur J Cancer 5:373–391.

    Article  PubMed  CAS  Google Scholar 

  22. Steel GG, Adams K, Stanley J. 1976. Size dependence of the response of Lewis lung tumors to BCNU. Cancer Treat Rep 60:1743–1748.

    PubMed  CAS  Google Scholar 

  23. Smith KA, Begg AC, Denekamp J. 1985. Differences in chemosensitivity between subcutaneous and pulmonary tumours. Eur J Cancer Clin Oncol 21:249–256.

    Article  PubMed  CAS  Google Scholar 

  24. Twentyman PR, Bleehen NM. 1976. The sensitivity to cytostatic agents of the EMT6 tumour in vivo. Comparative response of lung nodules in rapid exponential growth and of the solid flank tumor. Br J Cancer 32:320–328.

    Article  Google Scholar 

  25. Conzelman GM, Springer K. 1969. The influence of the anatomic location of a tumor on its susceptibility to chemotherapy. Cancer Chemother Rep 2(Part 1):105–113.

    Google Scholar 

  26. Kal HB, Van Berkel AH, Zürcher C, Smink T, Van Bekkum DW. 1986. A rat lung cancer model based on intrapulmonary implantation of tumour material. Radiother Oncol 6:231–238.

    Article  PubMed  CAS  Google Scholar 

  27. Kal HB, Van Berkel AH, Van der Vecht-de Jong B, Van Bekkum DW, Zürcher C. 1988. Development and application of a rat tumor model for human bronchial carcinoma. Natl Cancer Inst Monogr 6:111–114.

    Google Scholar 

  28. Kal HB, De Graaff E, Van Berkel AH, Goedoen HH. 1992. Responses of experimental rat tumours and a mouse colon tumour to flavone acetic acid. In Vivo 6:73–76.

    CAS  Google Scholar 

  29. Damia G, Freschi A, Sorio R, Braida A, Caruso G, Quaia M, Monfardini S, DTncalci M. 1990. Flavone acetic acid distribution in human malignant tumours. Cancer Chemother Pharmacol 26:67–70.

    Article  PubMed  CAS  Google Scholar 

  30. Kal HB, Meijnders PJN, Van Berkel AH, Van Bekkum DW. 1991. Response to chemotherapy of non-small cell bronchial rat tumours growing subcutaneously or in the lung. In Vivo 5:301–306.

    CAS  Google Scholar 

  31. Kal HB, Van Berkel AH, Broers JLV, Klein JC, Mijnheere EP, Roholl PJM, Zürcher C, Ramaekers FCS. 1993. Cytokeratins expressed in experimental rat bronchial carcinomas. Int J Cancer 53:506–513.

    Article  PubMed  CAS  Google Scholar 

  32. Broers JLV, Ramaekers FCS, Klein Rot M, Oostendorp T, Huijsmans A, Van Muijen GNP, Wagenaar SS, Vooijs GP. 1988. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 48:3221–3228.

    PubMed  CAS  Google Scholar 

  33. Moll R, Franke WW, Schiller DL, Geiger B, Krepier R. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11–24.

    Article  PubMed  CAS  Google Scholar 

  34. Noteboom JL, Valerio D, Van Bekkum DW. 1993. Interleukin-2 gene transfer into a non-immunogenic bronchial tumor cell line reduces tumor take rate and induces anti-tumor immunity. Symposium on Molecular and Cellular Biology. J Cell Biochem 17D(Suppl):135.

    Google Scholar 

  35. Trott K-R. 1987. Differences between mouse and human tumors that affect their responses to radiotherapy. In Rodent Tumor Models in Experimental Cancer Therapy, RF Kallman (ed.). Pergamon Press: New York, pp. 6–11.

    Google Scholar 

  36. Van Bekkum DW, Hagenbeek A. 1977. Relevance of the BN leukemia as a model for human acute myeloid leukemia. Blood Cells 3:565–575.

    Google Scholar 

  37. Flentje D, Flentje M, Valieriote F, Sapareto S. 1984. Analysis of MOPC-315 plasmacytoma by elutriation and flow cytometry. Cell Tissue Kinet 17:171–183.

    PubMed  CAS  Google Scholar 

  38. Marsoni S, Hoth D, Simon R, Leyland-Jones B, DeRosa M, Wittes RE. 1987. Clinical drug development: an analysis of phase II trials, 1970–1985. Cancer Treat Rep 71:71–80.

    PubMed  CAS  Google Scholar 

  39. Workman P. 1987. TCNU: a ray of hope for designer nitrosoureas? Eur J Cancer Clin Oncol 23:1823–1827.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Henk B. Kal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Oncology 5074, Rigshospitalet, 9 Blegdamsvej, DK-2100, Copenhagen, Denmark

    Heine H. Hansen

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kal, H.B. (1994). In vivo models for testing of cytostatic agents in non-small cell lung cancer. In: Hansen, H.H. (eds) Lung Cancer. Cancer Treatment and Research, vol 72. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2630-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2630-8_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6128-2

  • Online ISBN: 978-1-4615-2630-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation